Skip to main content
Erschienen in: Reactions Weekly 1/2016

01.02.2016 | Case report

Eltrombopag/romiplostim

Myelofibrosis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Jayakar JP, et al. Persistent thrombopoietin mimetic induced myelofibrosis in a woman with chronic refractory immune thrombocytopenia. Blood 126: 4659, No. 23, 3 Dec 2015 - Canada Jayakar JP, et al. Persistent thrombopoietin mimetic induced myelofibrosis in a woman with chronic refractory immune thrombocytopenia. Blood 126: 4659, No. 23, 3 Dec 2015 - Canada
Metadaten
Titel
Eltrombopag/romiplostim
Myelofibrosis: case report
Publikationsdatum
01.02.2016
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2016
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-016-14946-4

Weitere Artikel der Ausgabe 1/2016

Reactions Weekly 1/2016 Zur Ausgabe

Case report

Vancomycin

Case report

Brincidofovir

Case report

Pirarubicin

Case report

Levofloxacin